Literature DB >> 21679997

Significance of prostate adenocarcinoma perineural invasion on biopsy in patients who are otherwise candidates for active surveillance.

Turki Al-Hussain1, H Ballentine Carter, Jonathan I Epstein.   

Abstract

PURPOSE: Perineural invasion on biopsy is associated with extraprostatic extension at radical prostatectomy. To our knowledge the significance of perineural invasion on biopsy in patients who otherwise meet the criteria for active surveillance has not been studied.
MATERIALS AND METHODS: The biopsy criteria for active surveillance were Gleason score 6 or less, 2 or fewer positive cores and 50% or less involvement any positive core. All cases had at least 12 biopsy cores. A total of 313 cases met the biopsy criteria for active surveillance, and elected to undergo immediate radical prostatectomy at our institution between 1992 and 2008. These cases included 51 with perineural invasion and 262 without perineural invasion.
RESULTS: There was no significant difference in patient age and mean serum prostate specific antigen at diagnosis in cases with and those without perineural invasion. Cases with perineural invasion on biopsy had a higher maximum percentage of cancer on biopsy (18.6%) vs those without perineural invasion (15.0%, p=0.02). Cases with perineural invasion also had slightly more with 2 positive cores compared to cases without perineural invasion (56.9% and 39.7%, respectively, p=0.02). Despite a greater extent of cancer on biopsy, cases with and those without perineural invasion on biopsy showed no significant difference in surgical margin involvement (6% vs 7.3%, respectively) or organ confined disease (84.3% vs 91.6%, respectively).
CONCLUSIONS: Cases that meet biopsy criteria for active surveillance yet have perineural invasion showed no significant difference from those without perineural invasion in terms of adverse findings at radical prostatectomy. Patients with perineural invasion who meet criteria for active surveillance should not be excluded from this treatment option.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21679997     DOI: 10.1016/j.juro.2011.03.119

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy.

Authors:  Benjamin T Ristau; Jeffrey J Tomaszewski; Yi-Fan Chen; Marnie Bertolet; Elen Woldemichael; Joel B Nelson
Journal:  World J Urol       Date:  2014-11-01       Impact factor: 4.226

2.  Predicting the risk of non-organ-confined prostate cancer when perineural invasion is found on biopsy.

Authors:  Michael A Gorin; Heather J Chalfin; Jonathan I Epstein; Zhaoyong Feng; Alan W Partin; Bruce J Trock
Journal:  Urology       Date:  2014-03-19       Impact factor: 2.649

3.  Pathological Correlation between Number of Biopsies and Radical Surgery: Does It Make a Difference to Final Pathology?

Authors:  Tahir Qayyum; Jennifer M Willder; Paul G Horgan; Joanne Edwards; Mark A Underwood
Journal:  Curr Urol       Date:  2013-07-28

4.  Biopsy Perineural Invasion in Prostate Cancer Patients Who Are Candidates for Active Surveillance by Strict and Expanded Criteria.

Authors:  Robert M Turner; Todd S Yecies; Jonathan G Yabes; Benjamin T Ristau; Elen Woldemichael; Benjamin J Davies; Bruce L Jacobs; Joel B Nelson
Journal:  Urology       Date:  2016-11-15       Impact factor: 2.649

5.  Out-of-bounds: The significance of extraprostatic extension on multiparametric magnetic resonance imaging for local staging of prostate cancer.

Authors:  Melissa Huynh
Journal:  Can Urol Assoc J       Date:  2021-08       Impact factor: 1.862

6.  Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists.

Authors:  D M Berney; F Algaba; P Camparo; E Compérat; D Griffiths; G Kristiansen; A Lopez-Beltran; R Montironi; M Varma; L Egevad
Journal:  Virchows Arch       Date:  2014-03-04       Impact factor: 4.064

Review 7.  Nerves in cancer.

Authors:  Ali H Zahalka; Paul S Frenette
Journal:  Nat Rev Cancer       Date:  2020-01-23       Impact factor: 60.716

Review 8.  Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing.

Authors:  Hisham F Bahmad; Timothy Demus; Maya M Moubarak; Darine Daher; Juan Carlos Alvarez Moreno; Francesca Polit; Olga Lopez; Ali Merhe; Wassim Abou-Kheir; Alan M Nieder; Robert Poppiti; Yumna Omarzai
Journal:  Med Sci (Basel)       Date:  2022-02-18

9.  Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively.

Authors:  Amar S Ahmad; Vishnu Parameshwaran; Luis Beltran; Gabrielle Fisher; Bernard V North; David Greenberg; Geraldine Soosay; Henrik Møller; Peter Scardino; Jack Cuzick; Daniel M Berney
Journal:  Oncotarget       Date:  2018-04-17

10.  Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi-institutional analysis.

Authors:  Andrew R Barsky; Ryan D Kraus; Ruben Carmona; Patricia M G Santos; Carrie Li; Lauren E Schwartz; Leslie K Ballas; Neha Vapiwala
Journal:  Cancer Med       Date:  2020-03-18       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.